Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Targeted inactivation of Galpha(i) does not alter cardiac function or beta-adrenergic sensitivity.

Targeted inactivation of Galpha(i) does not alter cardiac function or beta-adrenergic sensitivity. . 2001 Feb; 280(2):H569-75.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.